
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases
Dna vaccines,lamp technology,allergy,oncology,animal health,and infectious diseases
Immunomic therapeutics, inc operates in the Biotechnology industry.
Immunomic therapeutics, inc's revenue is 11m - 100m
Immunomic therapeutics, inc has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.